BioNTech is trading 4.23% higher at $95.95, with no clear company-specific announcement explaining the gain. - Latest reported company news includes plans to close three German manufacturing sites, affecting up to 1,860 jobs; available coverage does not link this news to the upward move. - U.S. markets were rebounding after Thursday’s selloff, with easing oil prices and improved risk appetite cited as support. XBI is down 2.04%, and any broader-market link remains unconfirmed.